Wild Biotech Ltd
Wild Biotech offers a drug discovery platform that turns evolutionary biology and AI into novel therapeutics. It uses a database of millions of microbial genes and a proprietary catalog of miniproteins and peptides, with machine learning for molecule mining and synthetic biology for screening. Validation occurs through bioactivity testing and in vivo characterization. Core technology includes AI, machine learning, computational biology, synthetic biology, and protein language models, forming a B2B drug discovery platform for pharmaceutical partnerships. The company targets immune and cardiometabolic disorders and is pursuing IND and human proof-of-concept milestones.
Wild Biotech Ltd
Wild Biotech offers a drug discovery platform that turns evolutionary biology and AI into novel therapeutics. It uses a database of millions of microbial genes and a proprietary catalog of miniproteins and peptides, with machine learning for molecule mining and synthetic biology for screening. Validation occurs through bioactivity testing and in vivo characterization. Core technology includes AI, machine learning, computational biology, synthetic biology, and protein language models, forming a B2B drug discovery platform for pharmaceutical partnerships. The company targets immune and cardiometabolic disorders and is pursuing IND and human proof-of-concept milestones.